The global pet cancer therapeutics market is witnessing robust growth, as highlighted in Straits Research’s latest comprehensive report. The market, valued at USD 395.74 million in 2022, is projected to expand significantly to USD 837.75 million by 2031, registering a remarkable compound annual growth rate (CAGR) of 8.69% over the forecast period (2023–2031). https://straitsresearch97.wordpress.com/2024/12/12/pet-cancer-therapeutics-market-developments-and-top-players-size-share-trends-and-future-scope-2024-2032/